ADI – Modified arginine deiminase as anti-tumor drug
Arginine deiminase (ADI) produces depletion of arginine and has been studied as a potential antitumor drug for the treatment of arginine-auxotrophic tumors such as hepato-cellular carcinoma (HCC) and malignant melanoma. These tumors that are sensitive to arginine depletion do not express a certain key enzyme in the synthesis of arginine from citrulline. Recent data showed that a pegylated form of ADI inhibits human melanomas and HCCs in vitro and in vivo. Furthermore, studies on human lymphatic leukemia cell lines confirmed ADI´s anti-angiogenic activity.
The main limitation for in vivo applications of numerous ADIs lies in their pH-dependant activity profile. ADI from Pseudomonas plecoglossicida (PpADI) for example has a pH optimum at 6.5. A shift from 6.5 to 7.5 (physiological conditions) results in an activity drop of approximately 80%. In order to shift the pH optimum, a directed-evolution protocol based on an adapted citrulline screening protocol in microtiter-plate format was developed and validated by the present invention. A proof of concept for ADI engineering resulted in an improved pH optimum and increased resistance under physiological and slightly alkaline conditions.
Further Information: PDF
PROvendis GmbH
Phone: +49 (0)208/94105 10
Contact
Dipl.-Ing. Alfred Schillert
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Red light therapy for repairing spinal cord injury passes milestone
Patients with spinal cord injury (SCI) could benefit from a future treatment to repair nerve connections using red and near-infrared light. The method, invented by scientists at the University of…
Insect research is revolutionized by technology
New technologies can revolutionise insect research and environmental monitoring. By using DNA, images, sounds and flight patterns analysed by AI, it’s possible to gain new insights into the world of…
X-ray satellite XMM-newton sees ‘space clover’ in a new light
Astronomers have discovered enormous circular radio features of unknown origin around some galaxies. Now, new observations of one dubbed the Cloverleaf suggest it was created by clashing groups of galaxies….